The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Minister @MarjoriePLC announced that our government is investing $80 million with @tfri_research for research on precision oncology that helps design cancer treatment based on a patient's genetic makeup so treatment is more likely to be effective against their specific tumour.
Investing in the Terry Fox Research Institute for precision oncology research to enhance equitable access across Canada.
Thank you @AMP_CMDKP @broadinstitute for the opportunity to speak about the proteomics and genomics of cardiometabolic diseases!
Grateful for all the great questions.
Recording available here:
Excited to be speaking at the “Voices of the Next Generation of Leaders in Genomic Medicine Research” symposium at #ASHG2026, hosted by @illumina
📅 Oct 20, 9 AM–12 PM
Honored to join this fantastic group to discuss genetics, multi-omics, cardiometabolic disease, and more!
➡️